Spruce Biosciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Spruce Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- SPRB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001683553
Board of directors
-
Bali Muralidhar · DirectorSince 2023
-
Camilla Simpson V · DirectorSince 2023
- Since 2023
-
Javier B. Szwarcberg · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Kirk Ways · DirectorSince 2023
-
Michael G. Grey · Director · Executive ChairmanSince 2023
-
Niall O'Donnell · DirectorSince 2023
-
Percival Barretto-Ko · DirectorSince 2023
-
Tiba Aynechi · DirectorSince 2023
Chief executives
Javier B. Szwarcberg
· Chief Executive Officer
Dates unknown
Board connections
6 of this board's directors also sit on 8 other boards.
- via Bali Muralidhar, Michael G. Grey and Niall O'Donnell
- via Camilla Simpson V
- via Daniel K. Spiegelman
- via Tiba Aynechi
- via Daniel K. Spiegelman
- via Michael G. Grey
- via Daniel K. Spiegelman
- via Daniel K. Spiegelman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 16, 2024 | Charlton Ralph William III Officer (CHIEF MEDICAL OFFICER) | Option exercise | +26,600 | — | — |
| Dec 16, 2024 | Gharib Samir M. Officer (PRESIDENT AND CFO) | Option exercise | +38,500 | — | — |
| Dec 16, 2024 | Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise | +89,700 | — | — |
| Dec 16, 2024 | Charlton Ralph William III Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −9,491 | $0.39 | $3,701 |
| Dec 16, 2024 | Gharib Samir M. Officer (PRESIDENT AND CFO) | Shares withheld for tax | −13,737 | $0.39 | $5,357 |
| Dec 16, 2024 | Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for tax | −32,005 | $0.39 | $12,482 |
| Dec 16, 2024 | Charlton Ralph William III Officer (CHIEF MEDICAL OFFICER) | Option exercise | +31,750 | — | — |
| Dec 16, 2024 | Gharib Samir M. Officer (PRESIDENT AND CFO) | Option exercise | +37,250 | — | — |
| Dec 16, 2024 | Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise | +111,000 | — | — |
| Dec 16, 2024 | Charlton Ralph William III Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −11,329 | $0.39 | $4,418 |
| Dec 16, 2024 | Gharib Samir M. Officer (PRESIDENT AND CFO) | Shares withheld for tax | −13,291 | $0.39 | $5,183 |
| Dec 16, 2024 | Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for tax | −39,605 | $0.39 | $15,446 |
| Dec 10, 2024 | Charlton Ralph William III Officer (CHIEF MEDICAL OFFICER) | Option exercise | +106,400 | — | — |
| Dec 10, 2024 | Gharib Samir M. Officer (PRESIDENT AND CFO) | Option exercise | +154,000 | — | — |
| Dec 10, 2024 | Javier B. Szwarcberg Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise | +358,800 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.